Johnson Amber E, Bell Yamira K, Hamm Megan E, Saba Samir F, Myaskovsky Larissa
Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Cardiol Ther. 2020 Dec;9(2):421-432. doi: 10.1007/s40119-020-00180-9. Epub 2020 May 31.
Patient-related factors determining implantable cardioverter-defibrillator (ICD) use for primary prevention of sudden cardiac death in patients with cardiomyopathy have not been well explored. To assess race and sex differences regarding ICD preferences in this patient population, we sought to analyze a diverse cohort of patients with heart failure (HF) with reduced ejection fraction.
We conducted qualitative interviews of 28 adults with severe HF and either (1) an ICD or (2) no ICD. Interviews were recorded, transcribed, and coded using an inductively developed codebook by independent investigators. Coding was fully adjudicated and transcripts were reviewed to identify themes.
We recruited patients between 12/2015 and 06/2017, primarily from the outpatient cardiology clinic (24/28 = 86%). Half were women (50%) and 13/28 (46%) were black. Eight did not have an ICD. Neither race nor sex was associated with ICD. Four themes emerged: (1) HF requiring an ICD is profoundly disruptive to patients' lives; (2) patients had positive, yet unrealistic opinions of ICDs; or (3) Patients had negative/ambivalent opinions of ICDs; (4) medical decision-making included aspects of shared decision-making and informed consent.
Patients without ICDs perceived less benefit from ICDs and had less decision support. Participants viewed conversations with providers as insufficient. Needed interventions include the development and validation of processes for informed decisions about ICDs.
在心肌病患者中,决定使用植入式心脏复律除颤器(ICD)进行心脏性猝死一级预防的患者相关因素尚未得到充分研究。为了评估该患者群体在ICD偏好方面的种族和性别差异,我们试图分析一组射血分数降低的心力衰竭(HF)患者。
我们对28名患有严重HF的成年人进行了定性访谈,这些患者要么(1)植入了ICD,要么(2)未植入ICD。访谈由独立调查人员进行记录、转录,并使用归纳开发的编码手册进行编码。编码经过全面裁决,并对转录本进行审查以确定主题。
我们在2015年12月至2017年6月期间招募患者,主要来自门诊心脏病诊所(24/28 = 86%)。一半为女性(50%),13/28(46%)为黑人。8名患者未植入ICD。种族和性别均与ICD无关。出现了四个主题:(1)需要植入ICD的HF对患者生活造成极大干扰;(2)患者对ICD有积极但不切实际的看法;(3)患者对ICD有消极/矛盾的看法;(4)医疗决策包括共同决策和知情同意的方面。
未植入ICD的患者认为ICD带来的益处较少,且决策支持较少。参与者认为与医疗服务提供者的沟通不足。所需的干预措施包括开发和验证关于ICD的知情决策流程。